Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine
Almohanad A. Alkayyal(King Abdullah International Medical Research Center), Ahmad Bakur Mahmoud(Taibah University)
Cited by 1
Related Papers
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
|Science Advances|2018|614